ACHN News. Halted trading and opened +7% but all known http://globenewswire.com/news-release/2016/09/23/874228/0/en/Achillion-Announces-100-SVR12-in-the-6-Week-and-8-Week-Cohorts-in-Janssen-s-Phase-2-Trial-Evaluating-the-Triple-Combination-Treatment-Regimen-Including-Odalasvir-AL-335-and-Simepre.html?f=22&fvtc=9&fvtv=United%20States